ClinicalTrials.Veeva

Menu

Comparison of the Predictability of Dentoalveolar Expansion With Two Clear Aligner Systems

U

University of Salamanca

Status

Completed

Conditions

Narrow Palate

Treatments

Device: Angel Aligner Pro
Device: Angel Aligner
Device: Invisalign expansion

Study type

Interventional

Funder types

Other

Identifiers

NCT07608302
UniversidadDSalamanca

Details and patient eligibility

About

To analyze the clinical predictability of transverse arch expansion achieved with two clear aligner systems (Invisalign, Angel Aligner-Angel Aligner Pro) by comparing planned and achieved dental movements through digital model analysis at different treatment stages using a repeatable and reproducible digital measurement technique.

Full description

The study population comprised 60 adult subjects (mean age: 33.93 ± 8.38 years) presenting with transverse maxillary and mandibular deficiencies requiring dentoalveolar expansion with clear aligners in both arches. Participants were divided into three homogeneous groups of 20 patients treated with different aligner systems: Angel Aligner-Angel Aligner Pro (Angelalign Technology Inc., Shanghai, China), and Invisalign (Align Technology Inc., San Jose, CA, USA). Digital models of the maxillary and mandibular arches were obtained at baseline (T1) using an iTero Element 5D intraoral scanner. Virtual treatment planning was performed using iOrtho (version 5.2) and ClinCheck (version 6.0 Pro) software, generating a virtual setup model (T2) that served as the reference for calculating prescribed orthodontic movements. After aligner fabrication, composite attachments were bonded using standardized protocols and manufacturer-provided templates to ensure reproducibility and accurate expression of planned tooth movements. Digital STL models obtained before treatment, after virtual setup, and at the end of treatment were analyzed using a repeatable and reproducible digital measurement technique to evaluate the predictability of transverse dentoalveolar expansion achieved with each aligner system.

Enrollment

60 patients

Sex

All

Ages

25 to 43 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients with a full permanent dentition
  • Absence of auxiliary orthodontic appliances
  • A clinical indication for transverse expansion in both dental arches
  • Complete diagnostic and treatment records
  • Treatment plans involving a minimum of 15 aligners before any refinement phase
  • Confirmed adequate compliance with aligner wear (20-22 hours per day)
  • patients with skeletal Class I or mild skeletal Class II or III relationships (ANB angle ranging from 0° to 4°

Exclusion criteria

  • Severe dental crowding (tooth size-arch length discrepancy exceeding -5 mm)
  • Active periodontal pathology
  • Treatment plans involving dental extractions

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 3 patient groups

Invisalign
Experimental group
Description:
The Invisalign group consisted of 20 patients treated with Invisalign clear aligners, with each aligner worn for 10 days before progressing to the next stage in the treatment sequence.
Treatment:
Device: Invisalign expansion
Angel aligner
Experimental group
Description:
The Angel Aligner group consisted of 20 patients treated with Angel Aligner clear aligners, with each aligner worn for 10 days before progressing to the next stage in the treatment sequence.
Treatment:
Device: Angel Aligner
Angel Aligner pro
Experimental group
Description:
The Angel Aligner Pro group consisted of 20 patients treated with Angel Aligner clear aligners. Each treatment stage included two aligners: an initial softer aligner worn for 7 days, followed by a second, more rigid aligner worn for 3 days before progressing to the next stage in the treatment sequence.
Treatment:
Device: Angel Aligner Pro

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems